Severe COVID-19 Infections-Knowledge Gained and Remaining Questions

JAMA Intern Med. 2021 Jan 1;181(1):9-11. doi: 10.1001/jamainternmed.2020.6047.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Adenosine Monophosphate / analogs & derivatives
  • Adenosine Monophosphate / therapeutic use
  • Adrenal Cortex Hormones / therapeutic use
  • Alanine / analogs & derivatives
  • Alanine / therapeutic use
  • Antiviral Agents / therapeutic use
  • COVID-19 / therapy*
  • COVID-19 Drug Treatment
  • Critical Care / methods
  • Critical Care Outcomes
  • Extracorporeal Membrane Oxygenation / methods
  • Hospital Mortality
  • Humans
  • Patient Positioning / methods
  • Prone Position
  • Respiration, Artificial / methods*
  • Respiratory Distress Syndrome / therapy*
  • SARS-CoV-2
  • Severity of Illness Index

Substances

  • Adrenal Cortex Hormones
  • Antiviral Agents
  • remdesivir
  • Adenosine Monophosphate
  • Alanine